Correlation Between Canntab Therapeutics and China Infrastructure

Can any of the company-specific risk be diversified away by investing in both Canntab Therapeutics and China Infrastructure at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Canntab Therapeutics and China Infrastructure into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Canntab Therapeutics Limited and China Infrastructure Construction, you can compare the effects of market volatilities on Canntab Therapeutics and China Infrastructure and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Canntab Therapeutics with a short position of China Infrastructure. Check out your portfolio center. Please also check ongoing floating volatility patterns of Canntab Therapeutics and China Infrastructure.

Diversification Opportunities for Canntab Therapeutics and China Infrastructure

0.0

Correlation Coefficient

Canntab Therapeutics  China Infrastructure

Pay attention - limited upside

The 3 months correlation between Canntab and China is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Canntab Therapeutics Limited and China Infrastructure Construct in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on China Infrastructure and Canntab Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Canntab Therapeutics Limited are associated (or correlated) with China Infrastructure. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of China Infrastructure has no effect on the direction of Canntab Therapeutics i.e., Canntab Therapeutics and China Infrastructure go up and down completely randomly.

Pair Corralation between Canntab Therapeutics and China Infrastructure

Assuming the 90 days horizon Canntab Therapeutics Limited is expected to generate 2.24 times more return on investment than China Infrastructure. However, Canntab Therapeutics is 2.24 times more volatile than China Infrastructure Construction. It trades about 0.05 of its potential returns per unit of risk. China Infrastructure Construction is currently generating about 0.03 per unit of risk. If you would invest  1.30  in Canntab Therapeutics Limited on September 16, 2024 and sell it today you would lose (1.29) from holding Canntab Therapeutics Limited or give up 99.23% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	29.03%
Values	Daily Returns

Canntab Therapeutics Limited  vs.  China Infrastructure Construct

Canntab Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Canntab Therapeutics Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable fundamental drivers, Canntab Therapeutics is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.

China Infrastructure

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days China Infrastructure Construction has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, China Infrastructure is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Canntab Therapeutics and China Infrastructure

The main advantage of trading using opposite Canntab Therapeutics and China Infrastructure positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Canntab Therapeutics position performs unexpectedly, China Infrastructure can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in China Infrastructure will offset losses from the drop in China Infrastructure's long position.

The idea behind Canntab Therapeutics Limited and China Infrastructure Construction pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.